HBIO

Harvard Biosci

• TipRanks·1d ago

  Twelve option delistings on August 24th

• Dow Jones·08/12 13:08

  Harvard Bioscience Price Target Raised to $7.50/Share From $6.00 by Benchmark

• Dow Jones·08/12 13:08

  Harvard Bioscience Is Maintained at Speculative Buy by Benchmark

• Benzinga·08/12 12:58

  Benchmark Maintains Speculative Buy on Harvard Bioscience, Raises Price Target to $7.5

• NASDAQ·08/11 13:34

  Harvard Bioscience's Q2 Revenue Rises 11%; Raises FY26 Growth Outlook

• TipRanks·08/11 11:32

  Harvard Bioscience Advances Transformation with Project Viking Launch

• Seeking Alpha·08/11 11:24

  Harvard Bioscience beats top-line and bottom-line estimates; gives Q3 and raises FY2026 outlook

• Dow Jones·08/11 11:10

  *Harvard Bioscience Sees 3Q Rev $21M-$22.6M >HBIO

• Dow Jones·08/11 11:10

  *Harvard Bioscience Sees 2026 Revenue Growth of 3% to 5% >HBIO

• Benzinga·08/11 11:05

  Harvard Bioscience Sees FY2026 Sales $89.147M-$90.877M vs $88.600M Est.

• Benzinga·08/11 11:03

  Harvard Bioscience Sees Q3 Sales $21.000M-$22.600M vs $21.850M Est

• Dow Jones·08/11 11:01

  Press Release: Harvard Bioscience Announces -2-

• Dow Jones·08/11 11:01

  Press Release: Harvard Bioscience Announces Second Quarter 2026 Financial Results

• Dow Jones·08/11 11:01

  *Harvard Bioscience 2Q Loss $2.91M >HBIO

• Dow Jones·08/11 11:01

  *Harvard Bioscience 2Q Adj Loss/Shr 14c >HBIO